Orthofix received FDA 510(k) clearance to market the G-Beam™ Fusion Beaming system, designed to provide alignment, stabilization and fixation to treat neuropathic deformities such as Charcot foot.
G-Beam is accompanied by single-use, sterile-packed implants and a compact instrumentation tray. The system supports the company’s strategy to be a premium provider for Charcot and diabetic foot markets.
Orthofix received FDA 510(k) clearance to market the G-Beam™ Fusion Beaming system, designed to provide alignment, stabilization and fixation to treat neuropathic deformities such as Charcot foot.
G-Beam is accompanied by single-use, sterile-packed implants and a compact instrumentation tray. The system supports the company's strategy to be a...
Orthofix received FDA 510(k) clearance to market the G-Beam™ Fusion Beaming system, designed to provide alignment, stabilization and fixation to treat neuropathic deformities such as Charcot foot.
G-Beam is accompanied by single-use, sterile-packed implants and a compact instrumentation tray. The system supports the company’s strategy to be a premium provider for Charcot and diabetic foot markets.
Copy to clipboard 
